No definition available.
Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo
AB1_OTHER_CONDITIONS_WIDE
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
691 |
4. Check minimum number of eventsNone |
691 |
5. Include endpointsNone |
691 |
6. Filter based on genotype QC (FinnGen only) |
544 |
Control definitions (FinnGen only)
- Control exclude
- AB1_HIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Human immunodeficiency virus [HIV] disease, including avohilmo
- Certain infectious and parasitic diseases, including avohilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 544 | 103 | 441 |
| Unadjusted period prevalence (%) | 0.17 | 0.04 | 0.20 |
| Median age at first event (years) | 40.36 | 38.75 | 40.74 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 660
- Matched controls
- 6600
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WW200
NOMESCO Finland
Immunization
392.3
307.7
527
66
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
33.1
307.7
390
276
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
+∞
307.7
640
*
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
+∞
307.7
350
*
Z25.1
ICD-10 Finland
Need for immunization against influenza
23.2
262.1
212
132
Z3231
NOMESCO Finland
Registered nurse
14.1
254.8
479
1041
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
239.6
215
*
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
+∞
208.7
189
*
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
13.0
201.5
236
271
Z2221
NOMESCO Finland
Medical doctor
7.3
145.7
380
1040
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
330.2
86.9
86
*
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
82.0
77
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
7.6
76.0
120
188
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
14.4
74.5
70
54
A51.0
ICD-10 Finland
Primary genital syphilis
393.0
72.1
71
*
Y25
ICPC
Fear sexually transm disease male
8.2
64.7
93
130
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
58.2
55
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
11.3
56.1
61
59
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
199.6
53.8
55
*
A63.0
ICD-10 Finland
Anogenital (venereal) warts
7.1
52.5
85
135
A54.5
ICD-10 Finland
Gonococcal pharyngitis
187.8
50.7
52
*
A51.9
ICD-10 Finland
Early syphilis, unspecified
490.9
46.9
46
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.6
45.9
123
310
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
45.8
393
2093
EB1AA, ,
SPAT
5.2
45.6
105
233
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
4.5
43.7
122
317
A53.9
ICD-10 Finland
Syphilis, unspecified
433.5
41.6
41
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
10.7
41.1
46
46
WX110, ,
SPAT
5.1
40.3
93
206
ZX114
NOMESCO Finland
Intramuscular
14.5
40.2
37
27
C10AA07
ATC
rosuvastatin; oral
2.8
37.6
309
1559
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
100.7
35.1
38
*
K02.9
ICD-10 Finland
Dental caries, unspecified
9.0
34.7
44
52
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.1
31.4
94
255
F43.29
ICD-10 Finland
Adaptation disorder UNS
6.5
29.7
50
82
Z3226
NOMESCO Finland
Physiotherapist
3.1
29.4
154
598
ULA02
NOMESCO Finland
Kolposcopy
4.6
29.2
73
172
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.7
29.0
56
105
WYA30, ,
SPAT
27.5
28.7
39
15
R4110
NOMESCO Finland
Physiotherapy
2.6
27.8
228
1116
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
5.0
26.5
60
130
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
26.2
25
*
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
4.5
26.1
68
165
TAB00
NOMESCO Finland
Lumbar puncture
4.7
26.1
63
144
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
7.3
25.3
38
55
N05CD07
ATC
temazepam; oral
3.7
25.0
87
261
XF400
NOMESCO Finland
ECG with 12 standard connections
3.0
24.6
130
504
ZXE00
NOMESCO Finland
One hour or less
2.3
23.8
278
1573
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.5
23.7
204
1009
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
7.7
23.1
33
45
Z2446
NOMESCO Finland
Social worker
3.8
22.5
73
208
Z71.8
ICD-10 Finland
Other specified counselling
2.3
22.5
264
1489
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
+∞
22.0
21
*
Z20.6
ICD-10 Finland
Contact with and exposure to human immunodeficiency virus [HIV]
35.1
21.3
27
8
K02.2
ICD-10 Finland
Caries of cementum
4.4
21.0
55
134
B90
ICPC
HIV-infection/AIDS
+∞
20.9
20
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
20.8
117
466
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
20.8
250
1415
D11
ICPC
Diarrhoea
2.9
20.5
113
446
J05AB11
ATC
valaciclovir; oral
2.7
20.2
122
504
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.3
20.2
219
1186
A01AB04
ATC
amphotericin B; local oral
5.9
20.1
37
66
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
59.5
20.0
23
*
O98.5
ICD-10 Finland
Other viral diseases complicating pregnancy, childbirth and the puerperium
205.9
19.7
20
*
Z3232
NOMESCO Finland
Midwife
3.8
19.5
62
174
WX290, ,
SPAT
4.4
19.1
49
117
J05AB01
ATC
aciclovir; systemic
2.4
18.5
160
783
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
18.3
162
801
A55
ICD-10 Finland
Chlamydial lymphogranuloma (venereum)
+∞
17.8
17
*
R50.9
ICD-10 Finland
Fever, unspecified
2.5
17.7
129
583
Z01.2
ICD-10 Finland
Dental examination
2.0
17.5
346
2323
S02.51
ICD-10 Finland
Fracture of tooth, open
2.8
17.4
96
377
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.2
17.4
47
117
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
43.2
17.4
21
5
UJF30
NOMESCO Finland
Ileoscopy through colon
2.9
17.4
90
342
B20.9
ICD-10 Finland
HIV disease resulting in unspecified infectious or parasitic disease
+∞
16.7
16
*
Y71
ICPC
Gonorrhoea male
+∞
16.7
16
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.5
16.7
123
557
N05CF01
ATC
zopiclone; oral
2.1
16.5
213
1220
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
16.4
233
1381
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.4
16.2
41
97
SPAT1263
SPAT
Sampling
0.4
16.1
71
1675
A97
ICPC
No disease
2.3
16.1
145
718
P19
ICPC
Drug abuse
7.1
15.8
24
35
ZXD35
NOMESCO Finland
Usual procedure
4.5
15.4
38
88
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.4
14.6
55
173
A56.4
ICD-10 Finland
Chlamydial infection of pharynx
153.3
14.5
15
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
14.4
112
518
TQW99
NOMESCO Finland
Other minor procedure on skin
4.2
14.3
39
98
EB1SA, ,
SPAT
3.2
14.0
57
188
B02.9
ICD-10 Finland
Zoster without complication
3.3
13.7
53
169
B23
ICD-10 Finland
Human immunodeficiency virus [HIV] disease resulting in other conditions
+∞
13.6
13
*
UJH02
NOMESCO Finland
Anoscopy
3.9
13.4
40
107
R74
ICPC
Upper respiratory infection acute
1.9
13.1
258
1683
J01MA12
ATC
levofloxacin; systemic
2.2
13.0
127
647
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
12.9
177
1024
TLC02
NOMESCO Finland
Simple extraction of IUD
5.1
12.7
27
55
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
15.8
12.7
20
13
B20.1
ICD-10 Finland
HIV disease resulting in other bacterial infections
+∞
12.5
12
*
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
132.4
12.5
13
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.4
12.3
45
139
SPAT1153
SPAT
Removal of sutures
0.3
12.0
41
1118
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
47.6
11.9
14
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.7
11.9
68
271
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
11.9
153
862
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
5.1
11.8
25
51
J01MA02
ATC
ciprofloxacin; systemic
1.8
11.7
246
1624
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
11.7
122
635
-1, ,
NOMESCO Finland
1.8
11.6
237
1552
5AB01, ,
NOMESCO Finland
+∞
11.5
11
*
A51.5
ICD-10 Finland
Early syphilis, latent
+∞
11.5
11
*
B20.0
ICD-10 Finland
HIV disease resulting in mycobacterial infection
+∞
11.5
11
*
A54.9
ICD-10 Finland
Gonococcal infection, unspecified
+∞
11.5
11
*
N06AB04
ATC
citalopram; systemic
2.0
11.4
136
745
KMAK, ,
NOMESCO Finland
1.8
11.3
374
2811
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
4.9
11.3
25
53
K05.31
ICD-10 Finland
Periodontitis pronounced
2.3
11.1
92
436
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.4
10.6
81
1569
EBA00, ,
SPAT
4.1
10.6
29
73
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
2.3
10.5
88
419
ZXA05
NOMESCO Finland
Left side
2.0
10.5
141
804
A52.9
ICD-10 Finland
Late syphilis, unspecified
+∞
10.4
10
*
B23.2
ICD-10 Finland
HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified
+∞
10.4
10
*
T74.1
ICD-10 Finland
Physical abuse
4.1
10.4
29
74
SPAT1301
SPAT
No procedures
0.3
10.4
38
1011
N05BA04
ATC
oxazepam; oral
1.9
10.3
162
972
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
8.1
10.2
22
28
SPAT1310
SPAT
Counselling related to known health issue
0.4
10.1
47
1119
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.3
10.0
38
120
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.6
10.0
60
245
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.3
10.0
37
979
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
8.3
9.9
21
26
M01AC06
ATC
meloxicam; systemic, rectal
0.5
9.9
79
1512
JN4BD
NOMESCO Finland
Extensive body CT
2.5
9.9
67
290
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.3
9.9
37
116
ZXA00
NOMESCO Finland
Right side
1.9
9.9
150
889
B17.1
ICD-10 Finland
Acute hepatitis C
26.5
9.8
13
5
EBA05, ,
SPAT
4.8
9.8
22
47
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
9.7
91
454
A52.3
ICD-10 Finland
Neurosyphilis, unspecified
+∞
9.4
9
*
N05BA01
ATC
diazepam; systemic, rectal
2.1
9.1
89
451
OAB43, ,
SPAT
0.6
9.0
154
2327
SPAT1097
SPAT
Recording of ECG
0.2
9.0
7
395
WNF00
NOMESCO Finland
Infection source and contact determination
24.4
8.9
12
5
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
12.8
8.9
15
12
B07.9
ICD-10 Finland
Verruca simplex
3.1
8.9
37
124
N87.1
ICD-10 Finland
Moderate cervical dysplasia
8.8
8.8
18
21
SPAT1249
SPAT
Treatment-related counselling outside office
0.5
8.8
79
1462
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.0
8.8
40
141
OAA67, ,
SPAT
0.4
8.8
56
1175
LDA10
NOMESCO Finland
Curettage of cervix uteri
4.2
8.8
23
56
C10AA01
ATC
simvastatin; oral
0.4
8.8
62
1250
M01AH05
ATC
etoricoxib; oral
0.6
8.6
282
3628
A23
ICPC
Risk factor NOS
2.1
8.5
80
399
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
8.5
190
1258
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.4
8.4
55
1146
3044A
ICD-9 Finland
Drug dependence, Amphetamine and other psychostimulant dependence
91.2
8.4
9
*
Y70
ICPC
Syphilis male
91.2
8.4
9
*
D07AB08
ATC
desonide; topical
2.2
8.4
77
380
B21.3
ICD-10 Finland
HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue
+∞
8.3
8
*
B20.3
ICD-10 Finland
HIV disease resulting in other viral infections
+∞
8.3
8
*
0788B
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[HIV-INFEKTIO,OIREISET TAUDINKUVAT]
+∞
8.3
8
*
A52.2
ICD-10 Finland
Asymptomatic neurosyphilis
+∞
8.3
8
*
A51.4
ICD-10 Finland
Other secondary syphilis
+∞
8.3
8
*
0788C
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[AIDS, IMMUUNIKATO]
+∞
8.3
8
*
O98.3
ICD-10 Finland
Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium
+∞
8.3
8
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
8.3
59
261
N07BA03
ATC
varenicline; oral
2.5
8.3
55
236
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.2
8.2
69
328
SPAT1324
SPAT
Screening procedure
0.2
8.2
7
370
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
7.7
8.2
18
24
Z30.2
ICD-10 Finland
Sterilization
0.2
8.2
9
407
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.5
8.0
27
79
D19
ICPC
Teeth/gum symptom/complaint
1.7
8.0
215
1490
SPAT1312
SPAT
General health counselling
0.4
8.0
55
1125
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.8
8.0
153
967
B37.4
ICD-10 Finland
Candidiasis of other urogenital sites
13.2
7.9
13
10
Z71.9
ICD-10 Finland
Counselling, unspecified
2.3
7.9
60
274
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.6
7.8
44
174
S29
ICPC
Skin symptom/complaint other
1.9
7.8
116
680
ZXD20
NOMESCO Finland
Day surgery
2.0
7.6
81
422
Z2445
NOMESCO Finland
Psychologist
2.8
7.6
38
141
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.4
7.6
37
872
EB1HA, ,
SPAT
3.7
7.5
23
63
D06BB04
ATC
podophyllotoxin; topical
2.3
7.5
57
260
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
3.6
7.5
24
68
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
7.5
127
774
WZC30, ,
SPAT
0.1
7.3
*
282
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
11.0
7.3
13
12
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
11.0
7.3
13
12
B20.4
ICD-10 Finland
HIV disease resulting in candidiasis
+∞
7.3
7
*
B21.0
ICD-10 Finland
HIV disease resulting in Kaposi sarcoma
+∞
7.3
7
*
D06BB10
ATC
imiquimod; topical
2.8
7.2
36
134
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
7.2
52
232
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.8
7.1
121
736
OAA80, ,
SPAT
0.4
7.1
39
877
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.2
7.1
64
313
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
7.1
52
234
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
3.9
7.0
20
52
RD210, ,
NOMESCO Finland
5.9
7.0
18
31
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
5.9
7.0
18
31
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.6
6.9
15
20
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.5
6.9
43
179
EB4VA, ,
NOMESCO Finland
0.4
6.9
37
838
R83
ICPC
Respiratory infection other
1.6
6.9
197
1379
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
6.9
478
4089
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
11.1
6.8
12
11
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.4
6.8
42
900
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.5
6.7
41
169
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.4
6.7
45
195
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
6.6
68
350
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.4
6.5
43
184
D82
ICPC
Teeth/gum disease
0.6
6.5
128
1904
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
6.3
6.5
16
26
T40.1
ICD-10 Finland
Poisoning: Heroin
70.5
6.4
7
*
D01AE16
ATC
amorolfine; topical
2.0
6.4
66
340
XX3DW
NOMESCO Finland
Time consuming IT work
0.2
6.4
8
337
EBA30
NOMESCO Finland
Extraction of root of tooth
2.3
6.4
46
205
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.6
6.4
35
137
N05AC01
ATC
periciazine; systemic
18.2
6.3
9
5
A53.0
ICD-10 Finland
Latent syphilis, unspecified as early or late
+∞
6.3
6
*
Z22.9
ICD-10 Finland
Carrier of infectious disease, unspecified
+∞
6.3
6
*
B20.2
ICD-10 Finland
HIV disease resulting in cytomegaloviral disease
+∞
6.3
6
*
B21.9
ICD-10 Finland
HIV disease resulting in unspecified malignant neoplasm
+∞
6.3
6
*
B16.9
ICD-10 Finland
Acute hepatitis B without delta-agent and without hepatic coma
+∞
6.3
6
*
B22.0
ICD-10 Finland
HIV disease resulting in encephalopathy
+∞
6.3
6
*
B20.7
ICD-10 Finland
HIV disease resulting in multiple infections
+∞
6.3
6
*
R06AE07
ATC
cetirizine; oral
1.5
6.2
255
1928
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
0.2
6.2
11
440
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.6
6.2
36
145
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
5.4
6.2
17
32
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.4
6.2
22
67
G47.3
ICD-10 Finland
Sleep apnoea
0.5
6.2
83
1371
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.3
6.2
12
453
WX892
NOMESCO Finland
Monitored bed care
2.2
6.1
52
249
N05BB01
ATC
hydroxyzine; systemic
2.5
6.1
37
153
Z01.7
ICD-10 Finland
Laboratory examination
1.7
6.0
108
666
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
6.0
78
1305
ZY010
NOMESCO Finland
Hospital outpatient
2.3
6.0
45
204
N05CF02
ATC
zolpidem; oral
1.7
6.0
110
683
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
602
159
420.46
307.65
9.2
3.9
130.45
362.91
mg/l
2.00
594
78
628
23
5611.90
307.65
19.4
1.2
3004.60
—
u/ml
—
389
0
504
541
36.18
307.65
2.6
3.2
27.80
129.56
u/l
0.62
498
473
569
29
1416.79
307.65
3.3
2.6
31.72
39.05
%
1.93
112
21
599
48
1340.39
307.65
3.2
1.9
32.58
37.70
%
1.26
599
48
119
13
111.45
231.56
3.6
1.6
—
—
—
0
0
603
1870
26.76
231.46
6.9
3.8
30.18
77.80
e6/l
1.04
280
1322
629
2130
42.58
220.71
18.1
3.7
29.31
35.36
u/l
5.68
629
2028
135
68
24.70
180.87
1.1
1.1
—
—
—
0
0
631
2520
35.23
175.94
22.6
11.0
0.00
0.00
e9/l
0.64
612
2069
641
2697
48.82
167.06
22.2
7.0
50.22
56.95
%
56.32
641
2619
220
294
10.72
165.75
6.8
1.9
—
—
—
0
0
641
2744
47.41
162.58
22.4
7.2
36.30
28.07
%
81.53
641
2646
648
2909
68.52
153.68
22.3
7.0
0.54
0.59
e9/l
10.82
639
2549
228
353
9.34
151.52
6.8
2.0
—
—
—
0
0
648
2970
66.00
148.45
22.3
7.1
2.18
1.94
e9/l
8.80
639
2664
648
3003
64.68
145.70
22.4
7.3
0.18
0.20
e9/l
4.43
638
2674
178
213
11.07
144.63
1.2
1.3
171.81
235.60
miu/ml
0.93
54
97
649
3194
62.92
131.47
23.2
10.7
3.07
4.13
e9/l
51.15
639
2803
612
2824
17.05
131.40
5.8
3.2
0.00
0.00
estimate
0.50
51
570
613
2854
17.12
129.71
5.9
3.2
0.00
0.01
estimate
0.79
49
511
612
2850
16.78
129.26
5.9
3.2
21.33
8.85
estimate
0.24
54
570
550
2515
8.12
110.30
2.4
1.9
1.44
1.54
mmol/l
1.75
541
2207
651
4189
41.62
105.45
14.3
8.7
75.80
78.20
u/l
1.10
651
4026
384
1415
5.10
95.35
3.4
3.1
0.23
0.38
e6/l
0.74
261
1009
268
821
4.81
81.98
2.8
2.9
1.92
1.29
e6/l
0.34
99
378
67
40
18.53
81.71
4.9
2.1
—
—
—
0
0
103
124
9.66
81.46
2.3
3.4
1.64
2.52
index
0.60
28
78
397
1641
4.56
81.35
3.4
3.2
34.80
77.23
e6/l
0.50
277
1241
258
780
4.79
79.98
5.1
1.9
—
—
—
0
0
271
852
4.70
79.88
5.6
2.0
—
—
—
0
0
274
890
4.55
76.96
2.8
2.8
1.11
1.02
e6/l
0.12
106
445
72
65
12.31
69.50
2.5
1.8
—
—
—
0
0
401
1896
3.84
62.81
4.2
3.7
9.48
9.10
mmol/l
0.68
392
1665
121
240
5.95
60.20
1.4
1.4
—
—
—
0
0
68
84
8.91
52.16
2.1
2.4
19.86
48.61
iu/ml
—
10
8
99
212
5.32
44.78
1.1
1.6
0.21
0.07
iu/ml
0.33
54
32
647
4908
17.16
41.56
33.4
17.2
13.29
13.43
%
2.36
647
4861
93
203
5.17
41.04
2.6
1.7
—
—
—
0
0
78
152
5.69
39.00
1.1
1.5
149.14
150.49
au/ml
0.03
22
47
652
5496
16.37
37.46
27.6
12.9
88.43
88.86
ml/min/173m2
0.26
644
5077
41
49
8.86
32.05
3.3
2.4
980.28
808.12
e6/l
0.37
29
41
83
203
4.53
31.70
1.5
1.8
1.22
1.46
g/l
1.69
73
188
36
37
10.23
31.46
6.5
3.3
45.15
23.62
mu/l
2.16
36
37
230
1090
2.70
30.34
2.8
2.7
3.58
4.53
e6/l
0.51
209
999
51
85
6.42
29.80
1.2
1.3
—
—
—
0
0
51
85
6.42
29.80
1.2
1.3
—
—
—
0
0
40
58
7.28
26.57
4.0
3.6
—
—
—
0
0
120
438
3.13
25.25
2.4
2.4
77.24
74.10
ml/min/173m2
0.47
61
182
536
4037
2.74
23.38
4.6
4.1
10.79
9.02
mm/h
2.38
529
3851
644
5449
8.50
22.63
10.4
5.6
35.53
38.89
mmol/mol
24.68
644
5244
625
5167
4.95
22.63
34.3
17.0
336.42
335.21
g/l
2.71
625
5148
226
1244
2.24
19.99
1.6
1.6
18.85
19.41
nmol/l
0.32
217
1106
32
55
6.06
18.06
1.1
1.0
—
—
—
0
0
25
13
19.93
16.98
1.3
1.3
—
—
—
0
0
638
5655
4.85
14.41
16.1
14.1
26.19
23.23
mg/l
1.22
507
4570
22
35
6.47
13.35
1.5
3.9
915.36
601.60
u/ml
0.68
22
35
72
289
2.67
12.43
1.7
1.3
—
—
—
0
0
70
277
2.71
12.42
1.7
1.7
—
—
—
0
0
653
6122
7.28
12.22
33.1
17.2
83.36
79.90
umol/l
4.44
653
6080
653
6142
6.96
11.35
26.8
11.4
32.67
31.95
u/l
0.48
653
6043
95
455
2.27
11.18
1.5
1.5
—
—
—
0
0
20
18
11.42
11.10
2.2
1.8
—
—
iu/ml
—
0
0
294
2074
1.75
11.02
1.9
1.9
94.74
97.03
pmol/l
0.47
171
1197
38
113
3.51
10.98
2.2
1.8
—
—
—
0
0
23
28
8.47
10.88
1.0
1.2
2.58
1.97
umol/l
2.12
23
22
124
2067
0.51
10.51
2.4
3.2
23.36
34.80
ng/l
0.82
55
1327
50
181
2.91
10.47
2.3
3.5
—
—
—
0
0
111
583
2.09
10.33
1.8
2.0
—
—
—
0
0
41
1032
0.36
9.94
1.5
2.1
3.56
3.83
ratio
0.42
31
827
180
1129
1.82
9.88
2.3
2.1
2.41
2.74
mg/l
1.04
160
1003
112
604
2.03
9.68
1.8
1.9
—
—
—
0
0
45
163
2.89
9.42
1.3
1.1
—
—
—
0
0
45
164
2.87
9.32
1.3
1.1
—
—
—
0
0
386
4636
0.60
9.23
3.3
3.6
58.45
52.27
u/l
0.71
372
4475
162
1025
1.77
8.48
3.1
3.8
100.00
673.10
ng/l
3.47
115
755
21
49
4.39
8.46
3.9
2.7
335.47
235.28
e6/l
1.01
15
43
12
535
0.21
8.07
7.3
6.1
—
—
—
0
0
149
2213
0.58
7.88
5.1
3.0
0.00
0.01
estimate
0.78
48
485
11
6
18.61
7.62
4.5
1.5
—
—
—
0
0
71
358
2.10
7.31
1.4
1.6
—
—
—
0
0
30
760
0.37
7.22
1.4
1.8
2.90
3.56
mmol/l
3.95
21
550
77
408
2.00
6.93
1.7
1.8
0.33
0.32
mg/l
0.09
48
222
20
53
3.86
6.85
4.3
2.0
—
—
—
0
0
281
2167
1.52
6.25
7.6
8.1
1.20
1.20
mmol/l
0.32
275
2036
88
514
1.82
5.91
2.7
3.6
0.25
1.85
mmol/l
2.77
73
446
23
76
3.10
5.70
1.3
1.4
—
—
—
0
0
108
678
1.71
5.66
2.3
3.4
10.53
8.71
umol/l
0.37
99
620
24
83
2.96
5.51
1.1
1.2
—
—
—
0
0
112
1664
0.61
5.48
5.3
2.7
0.00
0.01
estimate
1.47
48
457
31
129
2.47
5.04
2.0
3.8
—
2602.09
—
0
11
17
51
3.40
4.91
1.3
1.6
—
—
—
0
0
99
1469
0.62
4.71
6.3
3.3
0.00
0.00
estimate
0.80
52
523
160
1155
1.51
4.64
1.6
1.5
—
—
—
0
0
58
321
1.88
4.63
2.2
4.5
78.03
92.12
ng/l
1.00
58
292
179
2329
0.68
4.50
2.7
3.4
23.77
21.52
%
0.52
61
837
653
6344
3.76
4.38
35.8
20.9
239.41
246.46
e9/l
2.39
653
6257
16
427
0.36
4.30
1.1
1.2
0.89
0.92
g/l
0.09
16
427
653
6350
3.67
4.24
35.7
20.8
4.58
4.72
e12/l
11.63
653
6256
653
6350
3.67
4.24
37.3
21.5
42.34
42.21
%
0.36
653
6302
653
6348
3.70
4.23
35.8
20.8
93.33
90.46
fl
39.82
653
6307
14
34
4.18
4.23
3.2
4.9
1.00
0.88
index
0.21
14
34
79
494
1.68
4.20
3.1
3.3
—
—
—
0
0
16
420
0.37
4.15
1.1
1.1
1.46
1.44
g/l
0.11
16
420
6
233
0.25
4.11
2.8
3.2
24.90
24.76
mmol/l
—
6
225
653
6352
3.64
4.08
36.0
21.0
142.86
142.51
g/l
0.24
653
6309
116
802
1.54
4.08
1.8
2.0
—
—
—
0
0
14
42
3.38
4.06
3.4
4.7
21.71
13.03
index
1.73
14
34
240
2928
0.72
4.04
3.4
3.9
1.80
1.65
ug/l
0.18
226
2724
9
274
0.32
3.91
1.9
1.8
—
—
—
0
0
293
2425
1.37
3.89
7.2
8.6
1.20
1.20
mmol/l
0.86
273
2133
39
205
1.96
3.66
1.6
1.7
72.46
10.54
u/ml
—
8
55
215
1711
1.38
3.57
3.7
4.3
12.23
9.88
mg/mmol
0.25
149
1155
7
9
7.85
3.56
1.1
3.9
—
—
—
0
0
13
36
3.66
3.51
1.1
1.0
12.16
6.09
iu/ml
—
5
13
13
43
3.06
3.26
1.5
3.4
1030.85
1267.33
mg
0.23
13
43
28
138
2.07
3.15
1.8
1.3
17.77
18.05
e6/l
0.01
22
96
12
35
3.47
3.12
1.0
1.1
659.83
188.58
iu/ml
1.53
12
35
24
112
2.19
3.10
2.3
1.6
—
—
—
0
0
11
30
3.71
3.09
1.0
1.2
—
—
—
0
0
8
16
5.05
3.06
1.1
1.2
—
—
—
0
0
17
379
0.43
3.05
2.2
3.3
4.76
5.17
kpa
2.88
17
369
28
142
2.01
2.94
1.8
1.4
1139.00
1028.73
e6/l
0.04
22
106
13
46
2.86
2.93
1.2
1.1
—
—
—
0
0
268
2265
1.31
2.84
2.3
2.5
73.28
72.38
nmol/l
0.16
261
2116
165
1309
1.35
2.71
1.3
1.3
2.53
1.69
u/ml
0.30
15
408
111
825
1.42
2.71
2.3
2.4
30.80
29.55
s
1.82
111
809
206
2450
0.77
2.52
2.7
2.8
—
—
estimate
—
0
0
27
146
1.89
2.41
1.3
2.7
55.22
35.94
mg/l
1.41
27
113
6
12
5.03
2.40
1.0
2.0
—
—
—
0
0
454
4164
1.29
2.37
3.6
3.2
—
—
—
0
0
65
919
0.68
2.37
1.6
1.6
414.21
32716476.12
pmol/l
0.97
57
810
11
255
0.42
2.23
2.7
3.4
44.60
52.97
%
0.58
11
250
28
160
1.78
2.13
1.0
1.2
338.22
239.61
u/ml
0.64
18
101
26
146
1.81
2.09
1.2
2.7
43.51
45.45
mg/l
0.05
26
114
10
38
2.66
2.01
1.2
1.3
0.69
0.56
ratio
—
5
20
12
51
2.38
1.96
1.2
1.2
—
—
—
0
0
12
51
2.38
1.96
1.2
1.2
—
—
—
0
0
79
1041
0.73
1.93
1.4
1.3
25.92
24.20
iu/ml
0.06
20
308
154
1267
1.28
1.91
1.9
1.9
2.20
1.12
mg/l
0.50
123
977
12
52
2.33
1.88
1.2
1.2
—
—
—
0
0
12
52
2.33
1.88
1.2
1.2
—
—
—
0
0
27
159
1.73
1.88
1.1
1.3
600.63
514.29
mg/l
0.45
27
152
17
312
0.53
1.83
2.1
3.3
0.40
1.64
mmol/l
—
9
230
14
66
2.15
1.83
1.7
1.3
—
—
—
0
0
9
35
2.59
1.80
1.0
1.1
—
—
—
0
0
7
23
3.06
1.80
1.6
2.3
—
—
—
0
0
7
23
3.06
1.80
1.6
2.3
—
—
—
0
0
19
102
1.89
1.78
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
147
1.73
1.76
2.4
3.6
0.50
0.32
iu/ml
—
9
77
19
103
1.87
1.73
1.4
1.5
1.04
1.27
ratio
0.62
11
62
19
103
1.87
1.73
1.4
1.5
1.18
1.10
ratio
0.15
11
62
19
103
1.87
1.73
1.4
1.5
0.75
0.97
ratio
2.89
11
62
13
61
2.15
1.72
1.2
1.2
—
—
—
0
0
27
428
0.62
1.71
1.7
2.1
8.65
9.92
ug/l
0.11
22
402
12
55
2.20
1.68
1.2
1.2
—
—
—
0
0
20
112
1.81
1.66
1.4
1.3
2.93
3.95
u/ml
0.48
15
55
23
135
1.73
1.64
1.1
2.3
1.19
1.38
ratio
—
7
64
23
136
1.72
1.61
1.0
1.2
—
—
—
0
0
8
33
2.44
1.54
1.1
1.1
—
—
—
0
0
5
15
3.35
1.52
1.0
1.3
—
—
—
0
0
72
925
0.75
1.50
1.4
1.3
16.84
8.25
u/ml
0.27
16
379
0
45
0.00
1.50
0.0
2.0
—
—
—
0
0
5
16
3.14
1.44
1.0
1.2
—
—
—
0
0
12
60
2.02
1.38
1.2
2.4
—
—
—
0
0
0
37
0.00
1.34
0.0
2.0
—
—
—
0
0
0
38
0.00
1.34
0.0
2.0
—
—
—
0
0
136
1592
0.82
1.32
1.8
2.7
361.98
356.91
umol/l
0.25
122
1476
0
41
0.00
1.31
0.0
2.0
—
—
—
0
0
271
2449
1.18
1.30
2.8
3.0
141.79
151.50
ug/l
0.21
265
2354
10
48
2.10
1.28
1.5
2.5
—
—
—
0
0
5
19
2.64
1.22
1.2
1.1
—
—
—
0
0
78
626
1.28
1.20
1.7
1.6
859.52
1162.83
nmol/l
2.91
69
499
18
109
1.67
1.20
2.8
4.2
4.73
5.03
kpa
1.84
18
109
40
291
1.40
1.18
1.3
2.2
43.80
39.39
u/l
0.61
35
270
22
141
1.58
1.18
1.8
2.5
174.31
128.99
ug/min
0.21
15
78
0
33
0.00
1.16
0.0
1.8
—
0.38
—
0
9
19
118
1.63
1.16
1.4
1.3
1.45
4.70
u/ml
1.09
11
44
0
36
0.00
1.14
0.0
1.1
—
98.64
—
0
28
7
30
2.35
1.12
2.7
2.1
—
411.80
—
0
5
585
5682
1.26
1.10
17.9
16.2
3.91
3.98
mmol/l
9.93
575
5584
8
41
1.96
1.09
1.0
1.0
1789.50
1500.76
miu/ml
—
8
41
7
33
2.13
1.06
1.1
1.1
—
—
—
0
0
12
67
1.81
1.05
1.1
1.1
—
—
—
0
0
9
47
1.93
1.02
1.0
1.0
—
—
—
0
0
23
156
1.49
1.00
1.2
1.3
—
—
—
0
0
0
29
0.00
0.98
0.0
3.3
—
57.66
—
0
29
161
1809
0.85
0.97
2.4
2.6
0.67
0.68
ug/l
0.03
111
901
98
833
1.21
0.93
3.1
3.0
2.44
2.43
mmol/l
0.80
83
755
6
27
2.23
0.93
4.2
1.7
—
—
—
0
0
65
531
1.25
0.90
2.0
2.0
48.02
36.82
nmol/l
2.16
65
520
115
1320
0.84
0.90
2.5
3.3
886.33
956.06
ng/l
0.14
103
1088
110
950
1.19
0.89
2.6
4.2
0.82
0.82
mmol/l
0.05
102
912
13
79
1.66
0.88
1.1
1.4
—
—
—
0
0
8
45
1.79
0.84
1.1
1.2
—
—
—
0
0
8
45
1.79
0.84
1.1
1.2
—
—
—
0
0
6
32
1.88
0.82
1.3
3.2
—
63716.14
—
0
7
0
24
0.00
0.79
0.0
1.8
—
113.34
—
0
24
0
27
0.00
0.77
0.0
3.4
—
1.11
—
0
27
15
99
1.53
0.76
1.0
1.1
—
—
—
0
0
175
1588
1.14
0.76
5.3
3.6
2.36
2.35
mmol/l
0.83
160
1486
5
24
2.09
0.74
1.2
1.0
—
—
—
0
0
579
5660
1.19
0.74
16.9
16.1
139.20
139.72
mmol/l
6.75
572
5571
7
38
1.85
0.73
1.0
1.2
—
—
—
0
0
12
76
1.59
0.72
1.0
2.2
—
—
—
0
0
7
42
1.67
0.68
1.3
2.5
97.86
92.36
%
—
7
42
7
117
0.59
0.68
1.1
1.2
—
277.14
—
0
7
7
43
1.63
0.67
1.0
1.6
5.13
8.34
u/l
—
7
35
12
79
1.53
0.63
1.1
1.1
—
—
—
0
0
6
105
0.57
0.62
1.5
3.8
9.12
9.58
pmol/l
—
6
105
392
4079
0.90
0.62
3.0
3.6
13.74
14.57
pmol/l
11.48
375
3834
72
623
1.17
0.60
15.9
12.4
-0.20
0.96
mmol/l
1.70
59
522
0
20
0.00
0.60
0.0
1.3
—
9.14
—
0
20
488
5018
0.89
0.60
4.4
4.4
1.83
1.82
mu/l
0.06
473
4743
0
22
0.00
0.59
0.0
3.3
—
23.52
—
0
22
23
175
1.33
0.59
1.2
2.3
13.68
10.83
mg/l
2.45
23
169
111
1233
0.88
0.58
5.1
3.2
1.02
1.02
kg/l
1.70
80
787
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
35
1.72
0.58
1.0
1.2
—
—
—
0
0
5
87
0.57
0.56
1.4
1.3
7.28
7.21
mmol/l
—
5
80
17
124
1.38
0.56
1.6
1.5
12667.43
8869.55
e6/l
—
7
85
25
195
1.29
0.55
1.5
1.2
—
—
—
0
0
9
62
1.46
0.53
1.0
1.2
—
—
—
0
0
12
169
0.70
0.52
1.0
1.2
—
15.00
—
0
22
36
433
0.82
0.51
1.8
1.5
—
—
—
0
0
137
1257
1.11
0.51
2.5
2.4
—
—
—
0
0
15
200
0.74
0.48
2.8
2.5
23.32
24.60
mmol/l
1.52
15
200
8
119
0.67
0.46
1.0
1.9
—
—
—
0
0
0
15
0.00
0.41
0.0
8.5
—
11.13
—
0
15
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
2.0
—
—
—
0
0
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
8
113
0.70
0.37
1.4
1.3
—
—
—
0
0
10
135
0.74
0.36
1.0
1.2
—
0.97
—
0
7
121
1128
1.09
0.34
2.3
2.1
1.62
1.47
%
1.52
109
1014
32
274
1.18
0.34
1.2
1.4
17.50
19.52
iu/l
0.17
19
225
14
177
0.79
0.33
1.0
1.2
—
35.46
—
0
5
12
151
0.79
0.28
1.2
1.7
—
—
—
0
0
13
160
0.81
0.26
1.0
2.0
—
—
—
0
0
12
96
1.25
0.24
1.0
1.1
—
—
—
0
0
13
158
0.82
0.24
1.1
1.1
—
6.95
—
0
21
14
116
1.21
0.22
1.3
1.2
114.64
114.01
%
0.03
14
108
5
41
1.22
0.22
1.2
1.2
90.40
108.12
pmol/l
—
5
41
23
262
0.87
0.21
1.3
1.4
—
—
—
0
0
31
277
1.13
0.21
1.5
1.7
267.52
259.41
mu/l
0.14
31
259
0
11
0.00
0.21
0.0
1.2
—
0.48
—
0
6
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
2.3
—
39.25
—
0
12
12
145
0.82
0.21
1.0
1.8
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
1.22
—
0
13
13
155
0.84
0.20
1.1
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
11
132
0.83
0.18
1.5
1.3
—
—
—
0
0
14
120
1.17
0.16
1.3
1.2
—
—
—
0
0
12
102
1.18
0.15
1.7
1.5
—
—
—
0
0
14
121
1.16
0.15
1.1
1.6
—
—
—
0
0
33
304
1.09
0.14
1.3
1.5
11.30
6.23
u/l
0.77
19
246
7
86
0.81
0.14
1.3
1.5
234.29
298.31
mu/l
—
7
70
14
125
1.12
0.10
2.3
2.6
9.29
8.28
kpa
1.21
14
125
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
28
299
0.93
0.09
1.5
2.7
0.57
0.62
%
0.37
28
299
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
6
54
1.11
0.09
1.0
1.2
—
—
—
0
0
5
62
0.80
0.08
1.0
2.1
—
—
—
0
0
6
73
0.82
0.07
1.0
1.4
60.33
133.89
pmol/l
—
6
68
8
76
1.05
0.07
1.3
2.1
—
—
—
0
0
9
100
0.90
0.06
1.0
2.3
—
—
—
0
0
12
109
1.10
0.06
1.3
1.7
—
—
—
0
0
14
150
0.93
0.04
1.0
2.0
—
—
—
0
0
31
300
1.03
0.03
1.1
1.1
—
—
—
0
0
35
340
1.03
0.03
1.1
1.2
125.83
130.59
u/ml
—
6
127
11
117
0.94
0.01
1.2
1.5
217.09
169.47
pmol/l
0.94
11
117
14
134
1.05
0.00
1.0
1.2
—
46.12
—
0
12
231
2316
1.00
0.00
10.1
11.3
1.18
1.17
inr
0.11
182
1920
12
115
1.04
0.00
1.1
1.1
—
1.92
—
0
9
15
145
1.04
0.00
1.5
2.2
21.47
33.80
u/ml
0.69
15
139
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
1.23
—
0
7
5
56
0.89
-0.00
1.0
2.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
1.45
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
0.16
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
2.18
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.6
—
0.38
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
59
0.85
-0.00
2.2
2.7
2.56
6.98
umol/l
—
5
46
0
5
0.00
-0.00
0.0
6.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
5.20
—
0
5
0
6
0.00
-0.00
0.0
5.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_OTHER_CONDITIONS_WIDE – Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).